Meeting NewsVideo

VIDEO: AI-based diabetic retinopathy screening device shows ‘exceptional results’

VANCOUVER, British Columbia — Kaushal Solanki, PhD, founder and CEO of Eyenuk Inc., discusses study results of the EyeArt AI Screening System for autonomous detection of diabetic retinopathy at the Association for Research in Vision and Ophthalmology meeting.

The prospective, multicenter, pivotal clinical trial found “exceptional results,” according to Solanki.

 

 

VANCOUVER, British Columbia — Kaushal Solanki, PhD, founder and CEO of Eyenuk Inc., discusses study results of the EyeArt AI Screening System for autonomous detection of diabetic retinopathy at the Association for Research in Vision and Ophthalmology meeting.

The prospective, multicenter, pivotal clinical trial found “exceptional results,” according to Solanki.

 

 

    See more from Association for Research in Vision and Ophthalmology